Cholinergic stimulation of early growth response-1 DNA binding activity requires protein kinase C and mitogen-activated protein kinase kinase activation and is inhibited by sodium valproate in SH-SY5Y cells

Journal of Neurochemistry

Volumn 73, Issue 4, 1999, Pages 1384-1392

  Grimes, Carol A ^a   Jope, Richard S ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bipolar disorder; Carbamazepine; Early growth response l; Lithium; Protein kinase C; Sodium valproate

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CARBACHOL; CARBAMAZEPINE; EARLY GROWTH RESPONSE 1; GENISTEIN; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE; MUSCARINIC M3 RECEPTOR; PROTEIN KINASE C; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VALPROIC ACID;

ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARBACHOL; DNA, NEOPLASM; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; GENISTEIN; HUMANS; IMMEDIATE-EARLY PROTEINS; INDOLES; KINETICS; MALEIMIDES; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROBLASTOMA; PROTEIN KINASE C; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VALPROIC ACID;

EID: 0032841741     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0731384.x     Document Type: Article

References (33)

1. Altin J. G. A., Kujubu D. A., Raffioni S., Eveleth D. D., Herschman H. R., and Bradshaw R. A. (1991) Differential induction of primary-response (TIS) genes in PC12 pheochromocytoma cells and the unresponsive variant PC12nnr5*. J. Biol. Chem. 266, 5401-5406.
2. Arenander A. T., de Vellis J., and Herschman H. R. (1989) Induction of c-fos and TIS genes in cultured rat astrocytes by neurotransmitters. J. Neurosci. Res. 24, 107-114.
3. Asghari V., Wang J. F., Reiach J. S., and Young L. T. (1998) Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells. Mol. Brain Res. 58, 95-102.
4. Beckmann A. M. and Wilce P. A. (1997) Egr transcription factors in the nervous system. Neurochem. Int. 31, 477-510.
5. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Chen G., Yuan P., Hawver D. B., Potter W. Z., and Manji H. K. (1997) Increase in AP-1 transcription factor DNA binding activity by valproic acid. Neuropsychopharmacology 16, 238-245.
7. Christy B. and Nathans D. (1989) DNA binding site of the growth factor-inducible protein Zif268. Proc. Natl. Acad. Sci. USA 86, 8737-8741.
8. Coso O. A., Chiariello M., Kalinec G., Kyriakis J. M., Woodgett J., and Gutkind J. S. (1995) Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway. J. Biol. Chem. 270, 5620-5624.
9. Ebihara T. and Saffen D. (1997) Muscarinic acetylcholine receptor-mediated induction of zif268 mRNA in PC12D cells requires protein kinase C and the influx of extracellular calcium. J. Neurochem. 68, 1001-1010.
10. Enslen H. and Soderling T. R. (1994) Roles of calmodulin-dependent protein kinases and phosphatases in calcium-dependent transcription of immediate early genes. J. Biol. Chem. 269, 20872-20877.
11. Fordyce D. E., Bhat R. V., Baraban J. M., and Wehner J. M. (1994) Genetic and activity-dependent regulation of zif268 expression: association with spatial learning. Hippocampus 4, 559-568.
12. Gutkind J. S. (1998) Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene 17, 1331-1342.
13. Hodge C., Liao J., Stofega M., Guan K., Carter-Su C., and Schwartz J. (1998) Growth hormone stimulates phosphorylation and activation of Elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-related kinases 1 and 2. J. Biol. Chem. 273, 31327-31336.
14. Hughes P. and Dragunow M. (1994) Activation of pirenzepine-sensitive muscarinic receptors induces a specific pattern of immediate-early gene expression in rat brain neurons. Mol. Brain Res. 24, 166-178.
15. Humblot N., Esteve L., Burgun C., Aunis D., and Zwiller J. (1997) 5-Hydroxytryptamine induces TIS8/egr-1 and c-fos expression in PC12 cells: involvement of tyrosine protein phosphorylation. Eur. J. Neurosci. 9, 84-92.
16. Jope R. S. (1999) Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry 4, 117-128.
17. Jope R. S. and Song L. (1997) AP-1 and NFκB stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differentially sensitive to inhibition by lithium. Mol. Brain Res. 50, 171-180.
18. 2-adrenergic, and bradykinin receptors. J. Neurochem. 60, 902-907.
19. Lim C. P., Jain N., and Cao X. (1998) Stress-induced immediate-early gene, egr-1, involved activation of p38/JNK1. Oncogene 16, 2915-2926.
20. Mitchell F. M., Russell M., and Johnson G. L. (1995) Differential calcium dependence in the activation of c-Jun kinase and mitogen-activated protein kinase by muscarinic receptors in rat 1a cells. Biochem. J. 309, 381-384.
21. O'Donovan K. J., Tourtellotte W. G., Milbrandt J., and Baraban J. M. (1999) The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 22, 167-173.
22. Ozaki N. and Chuang D.-M. (1997) Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J. Neurochem. 69, 2336-2344.
23. Pacheco M. A. and Jope R. S. (1996) Phosphoinositide signaling in human brain. Prog. Neurobiol. 50, 255-273.
24. Pacheco M. A. and Jope R. S. (1998) Bipolar therapeutic agents modulate carbachol-stimulated AP-1 activation. Soc. Neurosci. Abstr. 24, 997.
25. Reiser C. O. A., Lanz T., Hofmann F., Hofer G., Rupprecht H. D., and Goppelt-Struebbe M. (1998) Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins. Biochem. J. 330, 1107-1114.
26. 2+-mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A. Biochem. J. 335, 505-511.
27. Unlap T. M. and Jope R. S. (1997) Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells. Neuropsychopharmacology 17, 12-17.
28. von der Kammer H., Mayhaus M., Albrecht C., Enderich J., Wegner M., and Nitsch R. (1998) Muscarinic acetylcholine receptors activate expression of the Egr gene family of transcription factors. J. Biol. Chem. 273, 14538-14544.
29. Wang J. F., Asghari V., Rockel C., and Young L. T. (1999) Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells. Neuroscience 91, 771-776.
30. Williams M. B. and Jope R. S. (1995) Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium. Psychopharmacology (Berl.) 122, 363-368.
31. Worley P. F., Christy P. A., Nakabeppu Y., Bhat R. V., Cole A. J., and Baraban J. M. (1991) Constitutive expression of zif268 in neocortex is regulated by synaptic activity. Proc. Natl. Acad. Sci. USA 88, 5106-5110.
32. Worley P. F., Bhat R. V., Baraban J. M., Erickson C. A., McNaughton B. L., and Barnes C. A. (1993) Thresholds for synaptic activation of transcription factors in hippocampus: correlation with long-term enhancement. J. Neurosci. 13, 4776-4786.
33. Yuan P. X., Chen G., Huang L. D., and Manji H. K. (1998) Lithium stimulates gene expression through the AP-1 transcription factor pathway. Mol. Brain Res. 58, 225-230.